Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 114

1.
2.

Encapsulated follicular thyroid tumor with equivocal nuclear changes, so-called well-differentiated tumor of uncertain malignant potential: a morphological, immunohistochemical, and molecular appraisal.

Liu Z, Zhou G, Nakamura M, Koike E, Li Y, Ozaki T, Mori I, Taniguchi E, Kakudo K.

Cancer Sci. 2011 Jan;102(1):288-94. doi: 10.1111/j.1349-7006.2010.01769.x. Epub 2010 Nov 10.

PMID:
21070478
[PubMed - indexed for MEDLINE]
3.

Differential expression of cytokeratins in follicular variant of papillary carcinoma: an immunohistochemical study and its diagnostic utility.

Baloch ZW, Abraham S, Roberts S, LiVolsi VA.

Hum Pathol. 1999 Oct;30(10):1166-71.

PMID:
10534163
[PubMed - indexed for MEDLINE]
4.

Application of CD56, P63 and CK19 immunohistochemistry in the diagnosis of papillary carcinoma of the thyroid.

El Demellawy D, Nasr A, Alowami S.

Diagn Pathol. 2008 Feb 6;3:5. doi: 10.1186/1746-1596-3-5.

PMID:
18254952
[PubMed]
Free PMC Article
6.

Cytological features of well-differentiated tumors of uncertain malignant potential: Indeterminate cytology and WDT-UMP.

Nishigami K, Liu Z, Taniguchi E, Koike E, Ozaki T, Mori I, Kakudo K.

Endocr J. 2012;59(6):483-7. Epub 2012 Apr 7.

PMID:
22484994
[PubMed - indexed for MEDLINE]
Free Article
7.

Can the microRNA signature distinguish between thyroid tumors of uncertain malignant potential and other well-differentiated tumors of the thyroid gland?

Lassalle S, Hofman V, Ilie M, Bonnetaud C, Puisségur MP, Brest P, Loubatier C, Guevara N, Bordone O, Cardinaud B, Lebrigand K, Rios G, Santini J, Franc B, Mari B, Al Ghuzlan A, Vielh P, Barbry P, Hofman P.

Endocr Relat Cancer. 2011 Sep 13;18(5):579-94. doi: 10.1530/ERC-10-0283. Print 2011 Oct.

PMID:
21778212
[PubMed - indexed for MEDLINE]
Free Article
8.

Thyroid tumours of uncertain malignant potential: frequency and diagnostic reproducibility.

Hofman V, Lassalle S, Bonnetaud C, Butori C, Loubatier C, Ilie M, Bordone O, Brest P, Guevara N, Santini J, Franc B, Hofman P.

Virchows Arch. 2009 Jul;455(1):21-33. doi: 10.1007/s00428-009-0798-7. Epub 2009 Jun 20.

PMID:
19543912
[PubMed - indexed for MEDLINE]
9.

Differential miRNA expression profiles in variants of papillary thyroid carcinoma and encapsulated follicular thyroid tumours.

Sheu SY, Grabellus F, Schwertheim S, Worm K, Broecker-Preuss M, Schmid KW.

Br J Cancer. 2010 Jan 19;102(2):376-82. doi: 10.1038/sj.bjc.6605493. Epub 2009 Dec 22.

PMID:
20029416
[PubMed - indexed for MEDLINE]
Free PMC Article
10.

Encapsulated papillary thyroid carcinoma, follicular variant: a misnomer.

Kakudo K, Bai Y, Liu Z, Ozaki T.

Pathol Int. 2012 Mar;62(3):155-60. doi: 10.1111/j.1440-1827.2011.02773.x. Epub 2012 Jan 30. Review.

PMID:
22360502
[PubMed - indexed for MEDLINE]
11.

Cytokeratin 19 immunoreactivity in the diagnosis of papillary thyroid carcinoma: a note of caution.

Sahoo S, Hoda SA, Rosai J, DeLellis RA.

Am J Clin Pathol. 2001 Nov;116(5):696-702.

PMID:
11710686
[PubMed - indexed for MEDLINE]
Free Article
12.

Lymphatic and blood vessel density in the follicular patterned lesions of thyroid.

Giorgadze TA, Baloch ZW, Pasha T, Zhang PJ, Livolsi VA.

Mod Pathol. 2005 Nov;18(11):1424-31.

PMID:
15920537
[PubMed - indexed for MEDLINE]
Free Article
13.

Expression of cytokeratin 19, HBME-1 and galectin-3 in neoplastic and nonneoplastic thyroid lesions.

Mataraci EA, Ozgüven BY, Kabukçuoglu F.

Pol J Pathol. 2012 Mar;63(1):58-64.

PMID:
22535608
[PubMed - indexed for MEDLINE]
14.

Can CD10 be used as a diagnostic marker in thyroid pathology?

Yegen G, Demir MA, Ertan Y, Nalbant OA, Tunçyürek M.

Virchows Arch. 2009 Jan;454(1):101-5. doi: 10.1007/s00428-008-0698-2. Epub 2008 Nov 25.

PMID:
19031085
[PubMed - indexed for MEDLINE]
15.
16.

Cytokeratin 19 and galectin-3 immunohistochemistry in the differential diagnosis of solitary thyroid nodules.

Beesley MF, McLaren KM.

Histopathology. 2002 Sep;41(3):236-43.

PMID:
12207785
[PubMed - indexed for MEDLINE]
17.

Potential diagnostic utility of CD56 and claudin-1 in papillary thyroid carcinoma and solitary follicular thyroid nodules.

Abd El Atti RM, Shash LS.

J Egypt Natl Canc Inst. 2012 Dec;24(4):175-84. doi: 10.1016/j.jnci.2012.10.002. Epub 2012 Nov 6.

PMID:
23159288
[PubMed - indexed for MEDLINE]
Free Article
18.

High-molecular-weight cytokeratin and cytokeratin-19 in the diagnosis of thyroid tumors.

Raphael SJ, McKeown-Eyssen G, Asa SL.

Mod Pathol. 1994 Apr;7(3):295-300.

PMID:
7520169
[PubMed - indexed for MEDLINE]
19.

MicroRNA analysis as a potential diagnostic tool for papillary thyroid carcinoma.

Chen YT, Kitabayashi N, Zhou XK, Fahey TJ 3rd, Scognamiglio T.

Mod Pathol. 2008 Sep;21(9):1139-46. doi: 10.1038/modpathol.2008.105. Epub 2008 Jun 27.

PMID:
18587330
[PubMed - indexed for MEDLINE]
Free Article
20.

A molecular expression signature distinguishing follicular lesions in thyroid carcinoma using preamplification RT-PCR in archival samples.

Denning KM, Smyth PC, Cahill SF, Finn SP, Conlon E, Li J, Flavin RJ, Aherne ST, Guenther SM, Ferlinz A, O'Leary JJ, Sheils OM.

Mod Pathol. 2007 Oct;20(10):1095-102. Epub 2007 Jul 27.

PMID:
17660800
[PubMed - indexed for MEDLINE]
Free Article

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk